Using a cell signaling‐focused CRISPR screen, this study revealed COX4I1 as a new vulnerability in acute myeloid leukemia (AML) via maintaining mitochondrial ultrastructure and oxidative phosphorylation. This evidence concerns the gene COX4I1 and acute myeloid leukemia.